Vivos (RDGL) Revenue (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,217.30% |
| Sep 30, 2025 | -87.47% |
| Jun 30, 2025 | -43.92% |
| Mar 31, 2025 | 435.50% |
| Dec 31, 2024 | -0.10% |
| Sep 30, 2024 | -62.96% |
| Jun 30, 2024 | 200.00% |
| Sep 30, 2023 | 7.69% |
| Jun 30, 2023 | 8.33% |
| Mar 31, 2023 | -7.68% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -38.10% |
| Jun 30, 2022 | -19.23% |
| Dec 31, 2019 | -81.25% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Jun 30, 2014 | -28.46% |
| Mar 31, 2013 | -62.81% |
| Dec 31, 2012 | 2.22% |
| Sep 30, 2012 | 34.30% |
| Jun 30, 2012 | -27.95% |
| Mar 31, 2012 | 41.79% |
| Dec 31, 2011 | -14.40% |
| Sep 30, 2011 | 28.83% |
| Jun 30, 2011 | -31.65% |
| Mar 31, 2011 | -82.50% |